Table 5 Microorganisms isolated within 30 days from the start date of ertapenem therapy
Microorganism* | Infection with new microorganism within 30 days of first date of ertapenem use (%) | Carbapenem resistance (%) |
|---|---|---|
Pseudomonas aeruginosa | 50 (5.5) | 25 (2.8) |
Stenotrophomonas maltophila | 21 (2.3) | 21 (2.3)** |
Acinetobacter baumannii | 27 (3.0) | 20 (2.2) |
Enterobacteriaceae (such as Klebsiella spp., E. coli, Proteus spp.) with ESBL production | 41 (4.5) | 8 (0.9) |